TherapeuticsMD, Inc. Operating Leases, Future Minimum Payments, Due in Four Years
TherapeuticsMD, Inc. (TXMD) had Operating Leases, Future Minimum Payments, Due in Four Years of $943.13 thousand as of 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears · last filed 2018-11-08
- 2018-09-30: Operating Leases, Future Minimum Payments, Due in Four Years $943.13K.
- 2018-06-30: Operating Leases, Future Minimum Payments, Due in Four Years $943.13K.
- 2018-03-31: Operating Leases, Future Minimum Payments, Due in Four Years $943.13K.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $943.13K.
| Period end | Operating Leases, Future Minimum Payments, Due in Four Years |
|---|---|
| 2018-09-30 | $943.13K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $943.13K 10-Q · filed 2018-07-30 |
| 2018-03-31 | $943.13K 10-Q · filed 2018-05-07 |
| 2017-12-31 | $943.13K 10-K · filed 2018-02-23 |
| 2017-09-30 | $1.11M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $1.11M 10-Q · filed 2017-08-03 |
| 2016-12-31 | $1.10M 10-Q · filed 2017-05-03 |
| 2016-09-30 | $810.23K 10-Q · filed 2016-11-04 |
| 2016-06-30 | $810.23K 10-Q · filed 2016-08-05 |
| 2015-09-30 | $388.98K 10-Q · filed 2015-11-05 |
| 2015-06-30 | $388.98K 10-Q · filed 2015-08-07 |
| 2015-03-31 | $388.98K 10-Q · filed 2015-05-07 |
| 2014-12-31 | $302.75K 10-K · filed 2015-03-12 |
| 2014-09-30 | $393.85K 10-Q · filed 2014-11-07 |
| 2013-12-31 | $393.85K 10-Q · filed 2014-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |